Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

130 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
M9657 Is a Bispecific Tumor-Targeted Anti-CD137 Agonist That Induces MSLN-Dependent Antitumor Immunity without Liver Inflammation.
Xu C, Zhou X, Webb L, Yalavarthi S, Zheng W, Saha S, Schweickhardt R, Soloviev M, Jenkins MH, Brandstetter S, Belousova N, Alimzhanov M, Rabinovich B, Deshpande AM, Brewis N, Helming L. Xu C, et al. Among authors: soloviev m. Cancer Immunol Res. 2024 Feb 2;12(2):195-213. doi: 10.1158/2326-6066.CIR-23-0243. Cancer Immunol Res. 2024. PMID: 38091375
Colocalized targeting of TGF-β and PD-L1 by bintrafusp alfa elicits distinct antitumor responses.
Lan Y, Yeung TL, Huang H, Wegener AA, Saha S, Toister-Achituv M, Jenkins MH, Chiu LY, Lazorchak A, Tarcic O, Wang H, Qi J, Locke G, Kalimi D, Qin G, Marelli B, Yu H, Gross AW, Derner MG, Soloviev M, Botte M, Sircar A, Ma H, Sood VD, Zhang D, Jiang F, Lo KM. Lan Y, et al. Among authors: soloviev m. J Immunother Cancer. 2022 Jul;10(7):e004122. doi: 10.1136/jitc-2021-004122. J Immunother Cancer. 2022. PMID: 35858707 Free PMC article.
Preclinical evidence for the effective use of TL-895, a highly selective and potent second-generation BTK inhibitor, for the treatment of B-cell malignancies.
Goodstal SM, Lin J, Crandall T, Crowley L, Bender AT, Pereira A, Soloviev M, Wesolowski JS, Iadevaia R, Schelhorn SE, Ross E, Morandi F, Ma J, Clark A. Goodstal SM, et al. Among authors: soloviev m. Sci Rep. 2023 Nov 21;13(1):20412. doi: 10.1038/s41598-023-47735-z. Sci Rep. 2023. PMID: 37989777 Free PMC article.
SNARE Modulators and SNARE Mimetic Peptides.
Khvotchev M, Soloviev M. Khvotchev M, et al. Among authors: soloviev m. Biomolecules. 2022 Nov 29;12(12):1779. doi: 10.3390/biom12121779. Biomolecules. 2022. PMID: 36551207 Free PMC article. Review.
Therapeutic Antibodies in Cancer Treatment in the UK.
Eltarhoni K, Kamel F, Ihebunezie K, Nisar P, Soloviev M. Eltarhoni K, et al. Among authors: soloviev m. Int J Mol Sci. 2022 Nov 23;23(23):14589. doi: 10.3390/ijms232314589. Int J Mol Sci. 2022. PMID: 36498915 Free PMC article. Review.
AC/DC Thermal Nano-Analyzer Compatible with Bulk Liquid Measurements.
Odarchenko Y, Kaźmierczak-Bałata A, Bodzenta J, Ferrari E, Soloviev M. Odarchenko Y, et al. Among authors: soloviev m. Nanomaterials (Basel). 2022 Oct 28;12(21):3799. doi: 10.3390/nano12213799. Nanomaterials (Basel). 2022. PMID: 36364575 Free PMC article.
130 results